Home/Filings/4/0001140361-12-019281
4//SEC Filing

Gallin Scott 4

Accession 0001140361-12-019281

CIK 0001379246other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 5:06 PM ET

Size

11.0 KB

Accession

0001140361-12-019281

Insider Transaction Report

Form 4
Period: 2012-04-02
Gallin Scott
Director
Transactions
  • Sale

    Common Stock

    2012-04-02$28.15/sh19,579$551,094108,633 total(indirect: See Notes 5 and 6)
  • Sale

    Common Stock

    2012-04-02$27.74/sh47,219$1,309,94061,414 total(indirect: See Notes 5 and 6)
  • Sale

    Common Stock

    2012-04-03$27.71/sh61,414$1,702,0090 total(indirect: See Notes 5 and 6)
Footnotes (6)
  • [F1]The reported sales were made pursuant to Rule 10b5-1 trading plans.
  • [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.90, inclusive. The reporting person undertakes to provide to Body Central Corp., any security holder of Body Central Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.35 to $27.91, inclusive. The reporting person undertakes to provide to Body Central Corp., any security holder of Body Central Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F4]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.32 to $28.00, inclusive. The reporting person undertakes to provide to Body Central Corp., any security holder of Body Central Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F5]Prior to the reported transactions, each of PineBridge PEP III Direct, L.P., PineBridge PEP IV Co-Investment, L.P., PineBridge Vantage Partners, L.P. and American International Group, Inc. Retirement Plan Master Trust (collectively, the "Relevant Entities") was the record holder of 2,480, 19,831, 100,638 and 5,263 shares of common stock of the issuer, respectively. Following the reported transactions, none of the Relevant Entities continues to own any shares of common stock of the issuer. Each of the Relevant Entities is advised by PineBridge Investments LLC ("PineBridge Investments"), which had sole voting power and sole investment power over these shares and was the beneficial owner of the shares held by the Relevant Entities.
  • [F6]Scott Gallin is a managing director of PineBridge Investments and may be deemed to have beneficially owned the shares of common stock held by these entities. Mr. Gallin disclaimed such beneficial ownership. Each of the Relevant Entities which previously held such shares as a record holder disclaimed beneficial ownership of the securities held of record by the other entities.

Documents

1 file

Issuer

BODY CENTRAL CORP

CIK 0001379246

Entity typeother

Related Parties

1
  • filerCIK 0001503259

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:06 PM ET
Size
11.0 KB